NCT06865456Not yet recruiting
Predictors of Survival of DKD Patients in Assiut University Hospital
Source: ClinicalTrials.gov · Last updated 7 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
In recent years, the global prevalence of diabetes has risen significantly. According to the 9th edition of the International Diabetes Federation Atlas, an estimated 463 million adults were living with diabetes in 2019, representing approximately 9.3% of the population, with an average annual increase of 51%. Diabetes is associated with multiple complications that can significantly impact patient outcomes . In 2019 alone, around 4.2 million deaths were attributed to diabetes and its complications, accounting for approximately 11.3% of all global deaths . In diabetic patients, several factors influence renal survival, including glycemic control, blood pressure management, lifestyle interventions, and pharmacological therapies such as renin-angiotensin-aldosterone system (RAAS) inhibitors, sodium-glucose co-transporter-2 (SGLT2) inhibitors, and glucagon-like peptide-1 (GLP-1) receptor agonists(9). Early detection of kidney dysfunction through biomarkers like estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (UACR) plays a pivotal role in improving renal outcomes. This study aims to evaluate the factors affecting Patients survival in diabetic patients, identify early predictors of renal function decline, and assess the effectiveness of current therapeutic strategies.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 129 (estimated)
- First submitted
- 4 Mar 2025
- Start date
- 1 May 2025
- Primary completion date
- 1 May 2026
- Lead sponsor
- Assiut University
- Diseases
- Chronic kidney disease
- NCT number
- NCT06865456
What you commit to
- Study type: Observational
- Planned participants: 129
- From 1 May 2025 to the primary completion date, 1 May 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- ● Chronic kidney diseases stage 1,2, and 3.
- Acute kidney injury.
- Patients with any other causes of CKD autoimmune disease
Who the study is looking for
- ● Patients age \> 18 years old
- Both sex
- diabetic patients with HbA1c level \>6.5( Type 1 and 2)
- Diabetic patients with CKD 4, 5 )
- HD Pt
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.